300,000 Shares in Ignyta Inc (RXDX) Acquired by Longfellow Investment Management Co. LLC

Longfellow Investment Management Co. LLC purchased a new stake in Ignyta Inc (NASDAQ:RXDX) in the 4th quarter, HoldingsChannel reports. The fund purchased 300,000 shares of the biopharmaceutical company’s stock, valued at approximately $8,010,000. Ignyta comprises approximately 1.9% of Longfellow Investment Management Co. LLC’s investment portfolio, making the stock its 25th largest holding.

Other institutional investors have also recently bought and sold shares of the company. Numeric Investors LLC bought a new stake in shares of Ignyta in the 2nd quarter valued at approximately $126,000. Trexquant Investment LP bought a new stake in shares of Ignyta in the 3rd quarter valued at approximately $152,000. Legal & General Group Plc grew its stake in shares of Ignyta by 71.9% in the 2nd quarter. Legal & General Group Plc now owns 12,681 shares of the biopharmaceutical company’s stock valued at $131,000 after purchasing an additional 5,306 shares during the period. Virtu KCG Holdings LLC bought a new stake in shares of Ignyta in the 2nd quarter valued at approximately $132,000. Finally, LMR Partners LLP bought a new stake in shares of Ignyta in the 3rd quarter valued at approximately $169,000. 71.51% of the stock is owned by hedge funds and other institutional investors.

Several research firms have recently weighed in on RXDX. Zacks Investment Research upgraded Ignyta from a “hold” rating to a “buy” rating and set a $30.00 price objective on the stock in a research note on Wednesday, January 10th. SunTrust Banks lowered Ignyta from a “buy” rating to a “hold” rating and upped their price objective for the company from $25.00 to $27.00 in a research note on Tuesday, December 26th. Ladenburg Thalmann Financial Services lowered Ignyta from a “buy” rating to a “neutral” rating in a research note on Tuesday, December 26th. Jefferies Group lowered Ignyta from a “buy” rating to a “hold” rating and set a $27.00 price objective on the stock. in a research note on Friday, December 22nd. Finally, Cantor Fitzgerald lowered Ignyta from an “overweight” rating to a “neutral” rating and upped their price objective for the company from $23.00 to $27.00 in a research note on Wednesday, December 27th. Six equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $26.33.

Ignyta Inc (NASDAQ RXDX) traded down $0.07 during midday trading on Friday, reaching $26.85. The company had a trading volume of 6,324,100 shares, compared to its average volume of 4,279,217. The company has a market cap of $1,780.00, a price-to-earnings ratio of -9.91 and a beta of 206.07. Ignyta Inc has a 1-year low of $4.60 and a 1-year high of $27.10. The company has a debt-to-equity ratio of 0.34, a quick ratio of 6.07 and a current ratio of 6.07.

Ignyta (NASDAQ:RXDX) last released its quarterly earnings results on Tuesday, November 7th. The biopharmaceutical company reported ($0.51) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.54) by $0.03. research analysts anticipate that Ignyta Inc will post -2.27 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This piece of content was first reported by BBNS and is owned by of BBNS. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this piece of content can be read at https://baseballnewssource.com/markets/300000-shares-in-ignyta-inc-rxdx-acquired-by-longfellow-investment-management-co-llc/1846937.html.

Ignyta Company Profile

Ignyta, Inc is a biotechnology company. The Company is focused on precision medicine in oncology. The Company is pursuing an integrated therapeutic (Rx) and companion diagnostic (Dx) strategy for treating cancer patients. The Company’s pipeline includes various compounds, such as entrectinib, RXDX-105, taladegib and RXDX-106.

Want to see what other hedge funds are holding RXDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ignyta Inc (NASDAQ:RXDX).

Institutional Ownership by Quarter for Ignyta (NASDAQ:RXDX)

Receive News & Ratings for Ignyta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ignyta and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish
Mother of Pittsburgh Pirates Player Elias Diaz Has Been Kidnapped
Mother of Pittsburgh Pirates Player Elias Diaz Has Been Kidnapped
Giants Will Retire No. 25 of Barry Bonds in August
Giants Will Retire No. 25 of Barry Bonds in August


Leave a Reply

 
© 2006-2018 BBNS.